{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:06:10Z","timestamp":1783994770407,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"National Science and Technology Council","award":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-182A-036-MY2, NSTC 112-2628-B-182-007-MY3, NSTC-113-2314-B-182-042-MY2, NSTC-114-2314-B-182-043, NSTC 114-2314-B-182A-061-MY3"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]},{"name":"Chang Gung Memorial Hospital Research Fund","award":["CORPG3P0281, CORPG3P0291, BMRP488"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, BMRP488"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02083-8","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:46:28Z","timestamp":1779288388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinically feasible framework to estimate tau pathology and clinical\u2013biological discordance in the Alzheimer\u2019s disease spectrum"],"prefix":"10.1186","volume":"18","author":[{"given":"Jung-Lung","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Chuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2083_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky R, Jessen F, Grimmer T, Levin J, Floel A, Peters O, Froelich L. Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain. 2023;146:842\u20139.","journal-title":"Brain"},{"key":"2083_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"2083_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"2083_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer\u2019s Disease. BioDrugs. 2024;38:5\u201322.","journal-title":"BioDrugs"},{"key":"2083_CR5","doi-asserted-by":"crossref","unstructured":"van Dyck C. Is there evidence for a continued benefit for long-term lecanemab treatment? A benefit\/risk update from long-term efficacy, safety and biomarker data. In Alzheimer\u2019s Association International Conference (AAIC). Philadelphia, PA, USA; 2024.","DOI":"10.1002\/alz.092094"},{"key":"2083_CR6","doi-asserted-by":"publisher","first-page":"e0254332","DOI":"10.1371\/journal.pone.0254332","volume":"16","author":"MR Libowitz","year":"2021","unstructured":"Libowitz MR, Wei K, Tran T, Chu K, Moncrieffe K, Harrington MG, King K. Regional brain volumes relate to Alzheimer\u2019s disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study. PLoS ONE. 2021;16:e0254332.","journal-title":"PLoS ONE"},{"key":"2083_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-220812","volume":"91","author":"J Wu","year":"2023","unstructured":"Wu J, Su Y, Zhu W, Jalili Mallak N, Lepore N, Reiman EM, Caselli RJ, Thompson PM, Chen K, Wang Y. Alzheimer\u2019s Disease Neuroimaging I: Improved Prediction of Amyloid-beta and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding. J Alzheimers Dis. 2023;91:637\u201351.","journal-title":"J Alzheimers Dis"},{"key":"2083_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","volume":"87","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, Lyoo CH, Ryu YH, Lee MS. Tau PET in Alzheimer disease and mild cognitive impairment. Neurology. 2016;87:375\u201383.","journal-title":"Neurology"},{"key":"2083_CR9","doi-asserted-by":"crossref","unstructured":"Choi KY, Lee JJ, Gunasekaran TI, Kang S, Lee W, Jeong J, Lim HJ, Zhang X, Zhu C, Won SY, et al. APOE Promoter Polymorphism-219T\/G is an Effect Modifier of the Influence of APOE epsilon4 on Alzheimer\u2019s Disease Risk in a Multiracial Sample. J Clin Med. 2019;8(8):1236\u201354.","DOI":"10.3390\/jcm8081236"},{"key":"2083_CR10","doi-asserted-by":"publisher","first-page":"e0289893","DOI":"10.1371\/journal.pone.0289893","volume":"18","author":"N Mukadam","year":"2023","unstructured":"Mukadam N, Marston L, Lewis G, Mathur R, Lowther E, Rait G, Livingston G. South Asian, Black and White ethnicity and the effect of potentially modifiable risk factors for dementia: A study in English electronic health records. PLoS ONE. 2023;18:e0289893.","journal-title":"PLoS ONE"},{"key":"2083_CR11","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20:5143\u201369.","journal-title":"Alzheimers Dement"},{"key":"2083_CR12","doi-asserted-by":"publisher","first-page":"e14297","DOI":"10.1002\/alz.14297","volume":"21","author":"KL Huang","year":"2025","unstructured":"Huang KL, Hsiao IT, Huang CW, Huang CG, Chang HI, Huang SH, Lin KJ, Ma MC, Huang CC, Chang CC. The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer\u2019s disease and tau burden. Alzheimers Dement. 2025;21:e14297.","journal-title":"Alzheimers Dement"},{"key":"2083_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"2083_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"2083_CR15","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Sr., Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"2083_CR16","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.neurobiolaging.2014.05.009","volume":"35","author":"YC Liao","year":"2014","unstructured":"Liao YC, Lee WJ, Hwang JP, Wang YF, Tsai CF, Wang PN, Wang SJ, Fuh JL. ABCA7 gene and the risk of Alzheimer\u2019s disease in Han Chinese in Taiwan. Neurobiol Aging. 2014;35:2423. e2427-2423 e2413.","journal-title":"Neurobiol Aging"},{"key":"2083_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nucmedbio.2010.02.003","volume":"37","author":"KJ Lin","year":"2010","unstructured":"Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, et al. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent\u2013a pilot study. Nucl Med Biol. 2010;37:497\u2013508.","journal-title":"Nucl Med Biol"},{"key":"2083_CR18","doi-asserted-by":"crossref","unstructured":"Weng CC, Hsiao IT, Yang QF, Yao CH, Tai CY, Wu MF, Yen TC, Jang MK, Lin KJ. Characterization of (18)F-PM-PBB3 ((18)F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy. Molecules. 2020;25(7):1750\u201363.","DOI":"10.3390\/molecules25071750"},{"key":"2083_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.26516","volume":"93","author":"JL Hsu","year":"2023","unstructured":"Hsu JL, Wei YC, Toh CH, Hsiao IT, Lin KJ, Yen TC, Liao MF, Ro LS. Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease. Ann Neurol. 2023;93:164\u201374.","journal-title":"Ann Neurol"},{"key":"2083_CR20","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013;9:S72\u201383.","journal-title":"Alzheimers Dement"},{"key":"2083_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Sr., Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1\u2013e1511.","journal-title":"Alzheimers Dement"},{"key":"2083_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s40846-025-00972-1","volume":"45","author":"S-Y Huang","year":"2025","unstructured":"Huang S-Y, Lin K-J, Lyu Z-J, Hsiao I-T. The Development of an Automatic Amyloid PET Quantification (AmPQ) Software with MR-based and MR-free Spatial Normalization. J Med Biol Eng. 2025;45:492\u2013501.","journal-title":"J Med Biol Eng"},{"key":"2083_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol. 2012;11:669\u201378.","journal-title":"Lancet Neurol"},{"key":"2083_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, et al. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"2083_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, Rabinovici GD, Jagust WJ. Alzheimer\u2019s Disease Neuroimaging I: Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease. NeuroImage. 2017;157:448\u201363.","journal-title":"NeuroImage"},{"key":"2083_CR26","doi-asserted-by":"publisher","first-page":"e213675","DOI":"10.1212\/WNL.0000000000213675","volume":"104","author":"AJ Mendes","year":"2025","unstructured":"Mendes AJ, Ribaldi F, Pievani M, Boccalini C, Garibotto V, Frisoni GB. Alzheimer\u2019s Disease Neuroimaging I: Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer\u2019s Association Workgroup 2024 for Alzheimer Disease. Neurology. 2025;104:e213675.","journal-title":"Neurology"},{"key":"2083_CR27","doi-asserted-by":"crossref","unstructured":"Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E. The Alzheimer\u2019s Disease Neuroimaging I: CAT: a computational anatomy toolbox for the analysis of structural MRI data. Gigascience 2024;13:1\u201313.","DOI":"10.1093\/gigascience\/giae049"},{"key":"2083_CR28","first-page":"207","volume":"30","author":"F Li","year":"2018","unstructured":"Li F, He H. Assessing the Accuracy of Diagnostic Tests. Shanghai Arch Psychiatry. 2018;30:207\u201312.","journal-title":"Shanghai Arch Psychiatry"},{"key":"2083_CR29","doi-asserted-by":"publisher","first-page":"e70426","DOI":"10.1002\/alz.70426","volume":"21","author":"MD Rudolph","year":"2025","unstructured":"Rudolph MD, Sutphen CL, Register TC, Lockhart SN, Rundle MM, Hughes TM, Bateman JR, Sai KKS, Whitlow CT, Craft S, Mielke MM. Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort. Alzheimers Dement. 2025;21:e70426.","journal-title":"Alzheimers Dement"},{"key":"2083_CR30","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1093\/brain\/awaa248","volume":"143","author":"CR Jack","year":"2020","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Ferman TJ, et al. Predicting future rates of tau accumulation on PET. Brain. 2020;143:3136\u201350.","journal-title":"Brain"},{"key":"2083_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awac299","volume":"146","author":"PS Insel","year":"2023","unstructured":"Insel PS, Young CB, Aisen PS, Johnson KA, Sperling RA, Mormino EC, Donohue MC. Tau positron emission tomography in preclinical Alzheimer\u2019s disease. Brain. 2023;146:700\u201311.","journal-title":"Brain"},{"key":"2083_CR32","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41593-025-02000-6","volume":"28","author":"R Ossenkoppele","year":"2025","unstructured":"Ossenkoppele R, Coomans EM, Apostolova LG, Baker SL, Barthel H, Beach TG, Benzinger TLS, Betthauser T, Bischof GN, Bottlaender M, et al. Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-beta status, APOE genotype and sex. Nat Neurosci. 2025;28:1610\u201321.","journal-title":"Nat Neurosci"},{"key":"2083_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2022.3157","volume":"79","author":"CH Wilkins","year":"2022","unstructured":"Wilkins CH, Windon CC, Dilworth-Anderson P, Romanoff J, Gatsonis C, Hanna L, Apgar C, Gareen IF, Hill CV, Hillner BE, et al. Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study. JAMA Neurol. 2022;79:1139\u201347.","journal-title":"JAMA Neurol"},{"key":"2083_CR34","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awad042","volume":"146","author":"CR Jack","year":"2023","unstructured":"Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ, Ramanan VK, Vemuri P, Mielke MM, Knopman DS, et al. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023;146:2029\u201344.","journal-title":"Brain"},{"key":"2083_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin JS, Yang HS, Schultz AP, Hanseeuw BJ, Hedden T, Viswanathan A, Gatchel JR, Marshall GA, Kilpatrick E, Klein H, et al. Vascular Risk and beta-Amyloid Are Synergistically Associated with Cortical Tau. Ann Neurol. 2019;85:272\u20139.","journal-title":"Ann Neurol"},{"key":"2083_CR36","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1161\/STR.0000000000000476","volume":"55","author":"FD Testai","year":"2024","unstructured":"Testai FD, Gorelick PB, Chuang PY, Dai X, Furie KL, Gottesman RF, Iturrizaga JC, Lazar RM, Russo AM, Seshadri S, et al. Cardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association. Stroke. 2024;55:e425\u201338.","journal-title":"Stroke"},{"key":"2083_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cvr\/cvae235","volume":"121","author":"EW Kjeldsen","year":"2025","unstructured":"Kjeldsen EW, Frikke-Schmidt R. Causal cardiovascular risk factors for dementia: insights from observational and genetic studies. Cardiovasc Res. 2025;121:537\u201349.","journal-title":"Cardiovasc Res"},{"key":"2083_CR38","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaneurol.2025.1100","volume":"82","author":"A Pichet Binette","year":"2025","unstructured":"Pichet Binette A, Smith R, Salvado G, Tideman P, Glans I, van Westen D, Groot C, Ossenkoppele R, Stomrud E, Parchi P, et al. Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease. JAMA Neurol. 2025;82:666\u201375.","journal-title":"JAMA Neurol"},{"key":"2083_CR39","doi-asserted-by":"publisher","first-page":"7831","DOI":"10.1002\/alz.14245","volume":"20","author":"J Lu","year":"2024","unstructured":"Lu J, Wang J, Wu J, Zhang H, Ma X, Zhu Y, Wang J, Yang Y, Xiao Z, Li M, et al. Pilot implementation of the revised criteria for staging of Alzheimer\u2019s disease by the Alzheimer\u2019s Association Workgroup in a tertiary memory clinic. Alzheimers Dement. 2024;20:7831\u201346.","journal-title":"Alzheimers Dement"},{"key":"2083_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-2011-110086","volume":"26","author":"MM Mielke","year":"2011","unstructured":"Mielke MM, Leoutsakos JM, Tschanz JT, Green RC, Tripodis Y, Corcoran CD, Norton MC, Lyketsos CG. Interaction between vascular factors and the APOE epsilon4 allele in predicting rate of progression in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;26:127\u201334.","journal-title":"J Alzheimers Dis"},{"key":"2083_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41398-022-01899-w","volume":"12","author":"D Shi","year":"2022","unstructured":"Shi D, Xie S, Li A, Wang Q, Guo H, Han Y, Xu H, Gan WB, Zhang L, Guo T. Alzheimer\u2019s Disease Neuroimaging I: APOE-epsilon4 modulates the association among plasma Abeta(42)\/Abeta(40), vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults. Transl Psychiatry. 2022;12:128.","journal-title":"Transl Psychiatry"},{"key":"2083_CR42","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1093\/brain\/awaf016","volume":"148","author":"C Cicognola","year":"2025","unstructured":"Cicognola C, Salvado G, Smith R, Palmqvist S, Stomrud E, Betthauser TJ, Johnson SC, Janelidze S, Mattsson-Carlgren N, Hansson O. Pichet Binette A: APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta. Brain. 2025;148:2373\u201383.","journal-title":"Brain"},{"key":"2083_CR43","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1002\/alz.14336","volume":"20","author":"LE Collij","year":"2024","unstructured":"Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Roe-Vellve N, Koglin N, Jovalekic A, Garcia DV, Drzezga A, et al. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium. Alzheimers Dement. 2024;20:9037\u201348.","journal-title":"Alzheimers Dement"},{"key":"2083_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00259-021-05191-9","volume":"48","author":"V Dore","year":"2021","unstructured":"Dore V, Krishnadas N, Bourgeat P, Huang K, Li S, Burnham S, Masters CL, Fripp J, Villemagne VL, Rowe CC. Relationship between amyloid and tau levels and its impact on tau spreading. Eur J Nucl Med Mol Imaging. 2021;48:2225\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2083_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr., Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13:205\u201316.","journal-title":"Alzheimers Dement"},{"key":"2083_CR46","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1093\/brain\/awab248","volume":"144","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Tudorascu DL, Therriault J, Mathotaarachchi S, Savard M, Lussier FZ, Tissot C, Chamoun M, Kang MS, et al. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages. Brain. 2021;144:3517\u201328.","journal-title":"Brain"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02083-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:01:56Z","timestamp":1783994516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02083-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02083-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to study procedures. The study protocol was approved by the Institutional Review Board of Chang Gung Memorial Hospital (CGMHIRB No. 201701837A0, 201700982A0, 201800984A0, 201802151A0, 202000067A0). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All data were analyzed and reported in a de-identified manner, and no individual-level identifiable information is included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}